Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale

Por Yassin, Sayf A, Aroda, Vanita R
Publicado no Drug Des Devel Ther (2017)

Upper and/or lower gastrointestinal adverse events with glucagon‐like peptide‐1 receptor agonists: Incidence and consequences

Por Horowitz, Michael, Aroda, Vanita R., Han, Jenny, Hardy, Elise, Rayner, Chris K.
Publicado no Diabetes Obes Metab (2017)

Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Met...

Por Rosenstock, Julio, Diamant, Michaela, Aroda, Vanita R., Silvestre, Louise, Souhami, Elisabeth, Zhou, Tianyue, Perfetti, Riccardo, Fonseca, Vivian
Publicado no Diabetes Care (2016)

Skin Intrinsic Fluorescence Correlates With Autonomic and Distal Symmetrical Polyneuropathy in Individuals With Type 1 Diabetes

Por Conway, Baqiyyah N., Aroda, Vanita R., Maynard, John D., Matter, Nathaniel, Fernandez, Stephen, Ratner, Robert E., Orchard, Trevor J.
Publicado em 2011

Skin Intrinsic Fluorescence Is Associated With Coronary Artery Disease in Individuals With Long Duration of Type 1 Diabetes

Por Conway, Baqiyyah N., Aroda, Vanita R., Maynard, John D., Matter, Nathaniel, Fernandez, Stephen, Ratner, Robert E., Orchard, Trevor J.
Publicado em 2012

Metabolic and Hormonal Changes Induced by Pioglitazone in Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Clinical Trial

Por Aroda, Vanita R., Ciaraldi, Theodore P., Burke, Paivi, Mudaliar, Sunder, Clopton, Paul, Phillips, Susan, Chang, R. Jeffrey, Henry, Robert R.
Publicado em 2009

Cross-Sectional Evaluation of Noninvasively Detected Skin Intrinsic Fluorescence and Mean Hemoglobin A1c in Type 1 Diabetes

Por Aroda, Vanita R., Conway, Baqiyyah N., Fernandez, Stephen J., Matter, Nathaniel I., Maynard, John D., Orchard, Trevor J., Ratner, Robert E.
Publicado em 2013

Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed‐ratio combination) vs insulin glargine across...

Por Wysham, Carol, Bonadonna, Riccardo C., Aroda, Vanita R., Puig Domingo, Manuel, Kapitza, Christoph, Stager, William, Yu, Christine, Niemoeller, Elisabeth, Souhami, Elisabeth, Bergenstal, Richard M.
Publicado no Diabetes Obes Metab (2017)

Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and...

Por Aroda, Vanita R., Rosenstock, Julio, Wysham, Carol, Unger, Jeffrey, Bellido, Diego, González-Gálvez, Guillermo, Takami, Akane, Guo, Hailing, Niemoeller, Elisabeth, Souhami, Elisabeth, Bergenstal, Richard M.
Publicado no Diabetes Care (2017)

Scientific Statement: Socioecological Determinants of Prediabetes and Type 2 Diabetes

Por Hill, James O., Galloway, James M., Goley, April, Marrero, David G., Minners, Regan, Montgomery, Brenda, Peterson, Gregory E., Ratner, Robert E., Sanchez, Eduardo, Aroda, Vanita R.
Publicado em 2013

Testosterone and depressive symptoms among men in the Diabetes Prevention Program

Por Kim, Catherine, Barrett-Connor, Elizabeth, Aroda, Vanita R., Mather, Kieren J., Christophi, Costas A., Horton, Edward S., Pi-Sunyer, Xavier, Bray, George A., Labrie, Fernand, Golden, Sherita Hill
Publicado no Psychoneuroendocrinology (2016)

Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials

Por O'Neil, Patrick M., Aroda, Vanita R., Astrup, Arne, Kushner, Robert, Lau, David C. W., Wadden, Thomas A., Brett, Jason, Cancino, Ana‐Paula, Wilding, John P. H.
Publicado no Diabetes Obes Metab (2017)

Effects of Weight Loss, Weight Cycling, and Weight Loss Maintenance on Diabetes Incidence and Change in Cardiometabolic Traits in the Diabetes Prevention Program

Por Delahanty, Linda M., Pan, Qing, Jablonski, Kathleen A., Aroda, Vanita R., Watson, Karol E., Bray, George A., Kahn, Steven E., Florez, Jose C., Perreault, Leigh, Franks, Paul W.
Publicado em 2014

Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study

Por Aroda, Vanita R., Edelstein, Sharon L., Goldberg, Ronald B., Knowler, William C., Marcovina, Santica M., Orchard, Trevor J., Bray, George A., Schade, David S., Temprosa, Marinella G., White, Neil H., Crandall, Jill P.
Publicado no J Clin Endocrinol Metab (2016)

Hormone Therapy Dose, Formulation, Route of Delivery, and Risk of Cardiovascular Events in Women: Findings from the WHI Observational Study

Por Shufelt, Chrisandra L., Merz, C. Noel Bairey, Prentice, Ross L., Pettinger, Mary B., Rossouw, Jacques E., Aroda, Vanita R., Kaunitz, Andrew M., Lakshminarayan, Kamakshi, Martin, Lisa W., Phillips, Lawrence S., Manson, JoAnn E.
Publicado em 2014

Effect of Long-term Metformin and Lifestyle in the Diabetes Prevention Program and its Outcome Study on Coronary Artery Calcium

Por Goldberg, Ronald B., Aroda, Vanita R., Bluemke, David A., Barrett-Connor, Elizabeth, Budoff, Matthew, Crandall, Jill P., Dabelea, Dana, Horton, Edward S., Mather, Kieren J., Orchard, Trevor J., Schade, David, Watson, Karol, Temprosa, Marinella
Publicado no Circulation (2017)

Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study

Por Aroda, Vanita R., Knowler, William C., Crandall, Jill P., Perreault, Leigh, Edelstein, Sharon L., Jeffries, Susan L., Molitch, Mark E., Pi-Sunyer, Xavier, Darwin, Christine, Heckman-Stoddard, Brandy M., Temprosa, Marinella, Kahn, Steven E., Nathan, David M.
Publicado no Diabetologia (2017)